A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

NCT04139304 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

NETWORK

Sponsor class

Conditions

Plasmablastic Lymphoma
Ann Arbor Stage I Diffuse Large B-Cell Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: Daratumumab
DRUG: Doxorubicin
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Prednisone
DRUG: Vincristine
DRUG: Vincristine Sulfate

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]